Akerna KERN, a software and compliance tech provider for the cannabis industry, has agreed to acquire the remaining 20% of Solo Sciences inc.
The closing of the options is expected to take place on July 31.
Solo Sciences' patent technology guarantees users instant authentication of packaged products by giving each product a unique digital fingerprint that can be later on confirmed by consumers.
"Akerna and solo sciences share a vision to protect consumers from dangerous counterfeit products," said Akerna CEO Jessica Billingsley in a prepared statement. "Today, more than one million solo*CODEs have been sold, a major milestone, and another step in our commitment to create the pre-eminent global technology platform, addressing the entire supply chain and its regulatory bodies through accountability and transparency."
Akerna has developed the first seed-to-sale enterprise resource planning software for the cannabis industry and moves forward with strategic acquisitions.
In addition to Solo science’s purchase, the company recently announced the acquisition of Ample Organics, a Canadian seed-to-sale platform.
Courtesy photo
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
